Gout: Tips on diagnosis, treatment, and patient education

Nurse Practitioner

Volumn 33, Issue 12, 2008, Pages 28-32

  Montgomery, Mariann ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGOUT AGENT; COLCHICINE; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; FEMALE; GOUT; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT EDUCATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLCHICINE; FEMALE; GLUCOCORTICOIDS; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC;

EID: 65849265458     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000342180.40414.be     Document Type: Article

References (27)

1. Edwards NL. Treatment-failure gout: A moving target. Arthritis and rheumatism. 2008;58 (9):2587-2590.
2. Kleinman NL, Brook RA, Patel PA, et al. Impact of gout on work absence and productivity. Value Health. 2007;10:231-237.
3. Wortman RL, Kelly WN. Gout and hyperuricemia. In Kelley's Textbook of Rheumatology. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005.
4. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 5th ed. St. Louis, MO: Mosby; 2006.
5. Stamp LK, O'Donnell JL, Chapman PT. Emerging therapies in the long-term management of gout and hyperuricemia. Intern Med J. 2007;37:258-266.
6. Adams MP, Holland LN, Bostwick PM. Pharmacology for Nurses: A Pathophysiological Approach. Upper Saddle River, NJ: Prentice-Hall; 2008.
7. Luk AJ. Epidemiology of hyperuricemia and gout. Am J Managed Care. 2005;11:443-450,465-468.
8. Wortman R, Schumacher H, Becker M, Ryan L. Crystal-induced Arthropathies: Gout, Pseudogout, and Apatite-associated Syndromes. New York, NY: Taylor & Francis Group, LLC; 2006.
9. Hollowell M, Thompson L, Pantanowitz L. Gout. ENT: Ear, Nose Throat J. 2008;87:132-133.
10. Corbett JV. Laboratory Tests and Diagnostic Procedures with Nursing Diagnoses. 7th ed. Upper Saddle River, NJ: Prentice-Hall; 2008.
11. Hoskison K, Wortmann R. Drugs Aging. 2007;24:21-36.
12. Becker MA, Jolly M. Clinical gout and the pathogenesis of hyperuricemia. In Arthritis and Allied Conditions: A Textbook of Rheumatology. 15th ed. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2005.
13. Eggebeen A. Gout: an update. Am Fam Physician. 2007;76:801-808.
14. Singh H, Tarralba K. Therapeutic challenges in the management of gout in the elderly. Geriatrics. 2008;63:13-20.
15. Sunkureddi P, Karnath BM. Clinical signs of gout. Hosp Physician. 2006;42:39-42.
16. Schlesinger N, Schumacher R, Catton M, Maxwell L. Colchine for acute gout. Cochrane Database Syst Rev. 2006.
17. Colchinine: safe use is critical. WHO Drug Inf. 2006;20(4):252.
18. Pascual E, Sivera F. Therapeutic advances in gout. Current Opinion in Rheumatology. 2007;19 (2):122-127.
19. Perez-Ruiz F, Schlesinger N. Management of gout. Scand J Rheumatol. 2008;37:81-89.
20. Doyle M. Gout. Pulse. 2006;66(39):66-67.
21. Tierney L, McPhee S, Papadakis M. Current Medical Diagnosis and Treatment. 44th ed. Stamford, CT: Appleton & Lange; 2008.
22. Singh H. Diagnosis and management of gout in the long-term care setting. Ann Long-Term Care. 2007;15:34-40.
23. Sarawate CA. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clinic Proc. 2006;81:925-934.
24. Gout: Joint pain and more. Harvard Men's Health Watch. 2007;12(5):1-3.
25. Risser N, Murphy M. Dairy products lower the risk of gout. Nurse Pract. 2004;29(10):76.
26. Pascual E. Therapeutic advances in gout. Curr Opin Rheumatol. 2007; 19:122-127.
27. Drug Facts and Comparisons. St. Louis, Mo: Lippincott Williams & Wilkins; 2007.